A patient-like swine model of gastrointestinal fibrotic strictures for advancing therapeutics

Gastrointestinal (GI) strictures are difficult to treat in a variety of disease processes. Currently, there are no Food and Drug Administration (FDA) approved drugs for fibrosis in the GI tract. One of the limitations to developing anti-fibrotic drugs has been the lack of a reproducible, relatively...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ling, Itani, Mohamad I., Salimian, Kevan J., Li, Yue, Gutierrez, Olaya Brewer, Hu, Haijie, Fayad, George, Donet, Jean A., Joo, Min Kyung, Ensign, Laura M., Kumbhari, Vivek, Selaru, Florin M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233336/
https://www.ncbi.nlm.nih.gov/pubmed/34172773
http://dx.doi.org/10.1038/s41598-021-92628-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233336/
https://www.ncbi.nlm.nih.gov/pubmed/34172773
http://dx.doi.org/10.1038/s41598-021-92628-8

Ejemplares similares